Effects of process and formulation parameters on characteristics and internal morphology of poly(D,L-lactide-co-glycolide) microspheres formed by the solvent evaporation method

被引:134
作者
Mao, Shirui [1 ,2 ]
Shi, Yi [3 ]
Li, Luk [3 ]
Xu, Jing [1 ]
Schaper, Andreas [4 ,5 ]
Kissel, Thomas [1 ]
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China
[3] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
[4] Univ Marburg, Dept Geosci, D-35032 Marburg, Germany
[5] Univ Marburg, Ctr Mat Sci, D-35032 Marburg, Germany
关键词
PLGA; microspheres; internal morphology;
D O I
10.1016/j.ejpb.2007.06.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Taking ABT627 as a hydrophobic model drug, poly-(lactic-co-glycolic acid) (PLGA) microspheres were prepared by an emulsion solvent evaporation method. Various process parameters, such as continuous phase/dispersed phase (CP/DP) ratio, polymer concentration, initial drug loading, polyvinyl alcohol concentration and pH, on the characteristics of microspheres and in vitro drug release pattern of ABT627 were investigated. Internal morphology of the microspheres was observed with scanning electron microscopy by stereological method. CP/DP is a critical factor in preparing microspheres and drug loading increased significantly with increasing CP/DP ratios accompanied by a remarkably decreased burst release. At CP/DP ratio 20, microspheres with a core-shell structure were formed and the internal porosity of the microspheres decreased with increasing CP/DP ratio. Increase in PLGA concentration led to increased particle sizes and decreased drug release rates. ABT627 release rate increased considerably with increasirig PVA concentrations in the continuous phase from 0.1% to 0.5%. The maximum solubility of ABT627 in PLGA was approximately 30%, under which ABT627 was dispersed in PLGA matrix in a molecular state. Increase in initial drug loading had no significant influence on particle size, drug encapsulation efficiency, burst release and internal morphology. However, drug release rate decreased at higher drug loading. Independent of process parameters, ABT627 was slowly released from the PLGA microspheres over 30 days, by a combination of diffusion and polymer degradation. During the first 13 days, ABT627 was mainly released by the mechanism of diffusion demonstrated by the unchanged internal morphology. In contrast, a core-shell structure of the microspheres was observed after being incubated in the release medium for 17 days, independent of drug loading, implying that the ABT627/PLGA microspheres degraded by autocatalytic effect, starting from inside of the matrix. In conclusion, hydrophobic drug release from the PLGA microspheres is mainly dependent on the internal morphology and drug distribution state in the microspheres. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:214 / 223
页数:10
相关论文
共 28 条
[1]  
Benny O, 2005, CLIN CANCER RES, V11, P768
[2]   Precise control of PLG microsphere size provides enhanced control of drug release rate [J].
Berkland, C ;
King, M ;
Cox, A ;
Kim, K ;
Pack, DW .
JOURNAL OF CONTROLLED RELEASE, 2002, 82 (01) :137-147
[3]   Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PDLLA microspheres [J].
Chung, TW ;
Huang, YY ;
Liu, YZ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (02) :161-169
[4]   INVESTIGATION ON PROCESS PARAMETERS INVOLVED IN POLYLACTIDE-CO-GLYCOLIDE MICROSPHERES PREPARATION [J].
CONTI, B ;
GENTA, I ;
MODENA, T ;
PAVANETTO, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (05) :615-622
[5]   Determination of the internal morphology of poly (D,L-lactide) microspheres using stereological methods [J].
Ehtezazi, T ;
Washington, C ;
Melia, CD .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (03) :301-314
[6]   Polymer microspheres for controlled drug release [J].
Freiberg, S ;
Zhu, X .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 282 (1-2) :1-18
[7]   Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Fu, K ;
Pack, DW ;
Klibanov, AM ;
Langer, R .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :100-106
[8]   The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [J].
Jain, RA .
BIOMATERIALS, 2000, 21 (23) :2475-2490
[9]   BIODEGRADABLE POLY(LACTIC ACID) AND POLY(LACTIDE-CO-GLYCOLIDE) MICROCAPSULES - PROBLEMS ASSOCIATED WITH PREPARATIVE TECHNIQUES AND RELEASE PROPERTIES [J].
JALIL, R ;
NIXON, JR .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :297-325
[10]   Clonazepam release from core-shell type nanoparticles in vitro [J].
Jeong, YI ;
Cheon, JB ;
Kim, SH ;
Nah, JW ;
Lee, YM ;
Sung, YK ;
Akaike, T ;
Cho, CS .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) :169-178